These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31463583)

  • 1. [Clinical pharmacists in palliative care: effects on drug therapy and drug expenses].
    Wolf C; Dörje F; Klein C; Ostgathe C
    Schmerz; 2019 Dec; 33(6):533-538. PubMed ID: 31463583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
    Muñoz-Pichuante D; Villa-Zapata L
    J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative care pharmacist interventions in a community hospital.
    Naidu D; Jones K; Kanyer D; Hausdorff J
    Am J Health Syst Pharm; 2018 Jul; 75(13):933-936. PubMed ID: 29941533
    [No Abstract]   [Full Text] [Related]  

  • 4. Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups.
    Claus BO; Robays H; Decruyenaere J; Annemans L
    J Eval Clin Pract; 2014 Dec; 20(6):1172-9. PubMed ID: 25470782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of pharmaceutical expertise in a palliative care team in Sweden.
    Norrström B; Cannerfelt IB; Frid H; Roos K; Ramström H
    Pharm World Sci; 2010 Dec; 32(6):829-34. PubMed ID: 21052836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D; Brummel AR; Miller DB
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of a liaison clinical pharmacist to an inpatient palliative care unit.
    Lucas C; Glare PA; Sykes JV
    Palliat Med; 1997 May; 11(3):209-16. PubMed ID: 9205654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncology pharmacist as part of the palliative treatment team.
    Crul M; Oosterhof P
    Int J Pharm Pract; 2020 Feb; 28(1):92-96. PubMed ID: 31576620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Palliative Care Pharmacist Interventions and Outcomes as Part of Inpatient Palliative Care Consult Service.
    Atayee RS; Sam AM; Edmonds KP
    J Palliat Med; 2018 Dec; 21(12):1761-1767. PubMed ID: 29957096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
    de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
    J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a Clinical Pharmacist Service in the Hospice Setting: Financial and Clinical Impacts.
    Richter C
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):256-259. PubMed ID: 31135238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital.
    Zaidi ST; Hassan Y; Postma MJ; Ng SH
    Pharm World Sci; 2003 Dec; 25(6):299-302. PubMed ID: 14689820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of a Clinical Pharmacist into an Interdisciplinary Palliative Care Outpatient Clinic.
    DiScala SL; Onofrio S; Miller M; Nazario M; Silverman M
    Am J Hosp Palliat Care; 2017 Nov; 34(9):814-819. PubMed ID: 27418599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
    Weant KA; Armitstead JA; Ladha AM; Sasaki-Adams D; Hadar EJ; Ewend MG
    Neurosurgery; 2009 Nov; 65(5):946-50; discussion 950-1. PubMed ID: 19834408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a clinical pharmacist in a multidisciplinary intensive care unit.
    Montazeri M; Cook DJ
    Crit Care Med; 1994 Jun; 22(6):1044-8. PubMed ID: 8205814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.